Institutional Review.docx

Institutional Review Board
Application FOR HUMAN
SUBJECTS Research
The University of Phoenix Institutional Review Board (IRB)
exists to ensure university compliance with federal regulations
regarding research involving human subjects. This application
is used to facilitate and document this compliance review.
Research projects which meet the federal definition for research
and the federal definition of human subjects must be approved
by the University of Phoenix IRB before any data collection
begins. If an IRB application is approved by the IRB and, later,
the nature of the research design, requirements, or site locations
change, a revised application describing these changes must be
submitted for reconsideration and approval by the IRB. This
application is intended as a stand alone document, so reference
to other documents or appendices of dissertation proposals or
other research studies does not substitute for direct provision of
that information as part of this application, either as a response
within a section or as an addendum. This application pertains
to both pilot studies and full studies. Please note that it is the
researcher’s responsibility to give complete and accurate
information about the nature of the proposed study, particularly
in terms of the effects on, and expectations for, subject
participants. Please note that you must document currency in
CITI certification as part of this application.
Name of Researcher(s)
City, State, and Country / School or College and University
Affiliation
(student, faculty, or staff and id)
Type of Research

(research study, *funded research, or other)
[Phoenix Arizona]
University of Phoenix
IRN: LEAVE THIS BLANK
* If research is funded, please complete the following agency
information. Otherwise, leave blank.
agency submitted to
submission date
location of project
/ /
1. Title of the Research Study/Dissertation: TREATMENT OF
COCAINE ADDICTION
2. Classification of the Study:
a) Will primary data collection from human subjects be done in
this study?
(|X|) Yes, original data only is collected from human
subjects and no archival data will be used.

(|_|) Yes, both original data from human subjects and
archival data will be collected and used.
(|_|) No, only archival data will be used.
b) Are the research study results generalizable or relevant to a
larger population or only relevant to one
Organization or entity?
(|_|) Results are generalizable to a larger population.
(|X|) Results are relevant only to one organization or
entity.
3. Purpose and Anticipated Study Goal(s) and Benefits:
Briefly describe the following:
The purpose of the study: To find out the best treatment
approach to cocaine drug abuse. Comment by owner: I
reworded that phrase because I though “drug addicts” was a
little harsh.
The anticipated study goal(s): To treat cocaine addicts using the
best treatment approach.
The benefits of the study to the subjects, to the organization,
and to society:
To the subjects, the study is a cocaine treatment scheme which
not only treats them but also a free of charge service which
otherwise would have been expensive.
To the organization, the study is meant to be a turning point

regarding approaches to cocaine treatment. However, the results
of the study would be academically useful to the organization.
To the society, the results of the study would be useful in
reducing the number of cocaine addicts as well as educating the
society on the dangers of cocaine addiction Comment by
owner: I inserted a synonym.
3.1 Data Usage and Ownership: If your research involves
access to, and/or use of, a pre-existing private or restricted
database (one that is not open access/publically available),
please briefly describe the type of data in the database, the
organization or individual owner or controller of the data, how
the data will be accessed and how data confidentiality will be
ensured.
a) Does this research study involve access to, or use of public,
open access databases or
datasets, resources, recruitment lists, contact
information for potential subjects or any other pre-
existing public data? (Note that “open access” means
free and available to the general public without
restriction or prior permission needed.)
(|X|) No (|_|) Yes (Please describe
here)
b) Does this research study involve access to, or use of
private databases or datasets, private resources or
recruitment lists, contact information for potential
subjects or any other pre-existing private data?
(|X|) No (|_|) Yes (Please describe
here and document permission granted for access and
use)

c) During data collection or subject recruitment, will
access be needed to any health information created,
received or archived by health care providers,
clearinghouses, or health care plans that pertains to the
past, present or future health conditions or provision of
health care to an individual living or deceased?
(|_|) Yes (|X|) No
(|_|) HIPAA compliance (if health records are used,
please discuss here and address HIPAA compliance)
d) Will school or student related data be collected in this
study?
(|_|) Yes, individual student data (|_|) Yes,
aggregate student data (|X|) No
(|_|) FERPA compliance (if student data is used,
please explain here and address FERPA compliance)
4. Project Description: Briefly explain and address the
following questions as indicated:
a) Who are the subjects of this study and where are they
located? (for example, lawyers in private practice in the State of
Ohio)
Prisoners detained in the United States of America.

Samples will be collected from various prisons. Comment by
owner: I think we should focus on one area of the USA
(Northwest states) or just one particular state (Wyoming).
; b) What are the subjects expected to do as participants in
this study and what is the time commitment involved? Please
explain. If class time is used, please describe the activities
planned for non-participants.
The subjects are supposed to be used for experimental
analysis on the efficacy of CBT and CM. The commitment time
involved is one year and 8 months. Comment by owner: CBT?
CM?
c) Will a pilot study be conducted before the primary data
collection occurs? (|_|) No (|X|) Yes
d) What is the research method and design? Check all that
apply:
(|_|) quantitative analysis (|_|) qualitative analysis
(|_|) mixed methods
(|_|) phenomenological (|_|) case study (|X|)
experimental (|_|) quasi experimental (|_|) Delphi
(|_|) other (specify)
___________________________________________
e) How will data be collected? Check any that apply:
(|X|) face to face interview (|_|) focus group (|_|)
online survey (|_|) mail survey (|_|) telephone survey
(|_|) onsite survey (|_|) email survey (|_|) Skype or
related technology
(|_|) other (specify) ____________________________
f) Where will data collection occur? Check any that apply

and specify the location(s) below.
(|X|) organizational site (|_|) online (|_|) private premises
(|_|) public facility (|_|) open access site
(|_|) other (|_|) not applicable
Location: __www.phoenixedu.com__ Comment by
owner: I added this; is it correct?
g) What is the degree or magnitude of risk/stress (physical,
psychological, emotional, legal, financial) to the
human subjects because of their participation in this
study?
(|X|) minimal risk/stress, not greater than encountered
in ordinary daily life/activities or routine tests.
(|_|) greater than minimal risk/stress with potential for
direct benefit to the individual subjects
(|_|) greater than minimal risk/stress with little/no
potential direct benefit to individual subjects
h) If greater than minimal risk/stress to the human subject is
possible, please explain how the risk/stress will be mitigated or
lessened.
i) Are any third parties assisting with this study that will
have access to the data?
(|_|) No (|X|) Yes (specify) _Medical and psychological
professionals_____________________________________
j) Will any aspect of the study take place outside of the
United States?
(|X|) No (|_|) Yes (specify where)
_______________________________________
Note that IRB approval may be needed in the country
where research is taking place.

PLEASE PROVIDE HERE (OR AS AN ADDENDUM
TO THIS APPLICATION) ANY ADDITIONAL
INFORMATION
OR EXPLANATION THAT YOU THINK MAY BE
HELPFUL TO THE IRB REGARDING YOUR RESEARCH
STUDY
DESIGN OR IMPLEMENTATION.
5. Subject Groups: Will the subjects recruited to participate in
this study include any that are in protected groups identified
below as specified within the federal human subject guidelines?
(The guidelines are defined at www.citiprogram.org)
If any category from this list is checked “yes”, please
explain in the “Comments” area below how the subjects will be
protected from harm, risk, or stress as a study participant and
how stress/risk will be mitigated or lessened.
a. Children/minors under age 18?
Yes (|_|)
No (|X|)
b. Prisoners?
Yes (|X|)
No (|_|)
c. Pregnant women?
Yes (|_|)
No (|X|)

d. Cognitively impaired or mentally
disabled?
Yes (|_|)
No (|X|)
e. Educationally or economically
disadvantaged?
Yes (|_|)
No (|X|)
Will the subjects be traumatized, comatose, or terminally ill
patients?
Yes (|_|)
No (|X|)
Will the subjects be elderly or aged persons?
Yes (|_|)
No (|X|)
Will the subjects be minorities (including women)?
Yes (|_|)
No (|_|)
Will information be withheld from subjects prior to, or during,
participation?
Yes (|_|)
No (|X|)
Will the subjects be college students?
Yes (|_|)
No (|X|)
Will the subjects be deceived, misled, or coerced in any way?
Yes (|_|)
No (|X|)

Will/might the subjects be students of the University of
Phoenix?
Yes (|_|)
No (|X|)
Will/might the subjects be faculty or staff of the University of
Phoenix?
Yes (|_|)
No (|X|)
Will information be requested that is, or may be, personal or
sensitive?
Yes (|X|)
No (|_|)
If the subjects are active duty military, will their supervisors
have influence on their participation in this research or will
participation be affected at all by the reporting relationship(s)?
Yes (|_|)
No (|_|)
Will any aspect of this study involve subjects from countries
outside of the U.S.? If yes, please specify in the comments
section below.
Yes (|_|)
No (|X|)
Comments:
Prisoners are a good choice for the research owing to the fact
that they are more prevalent to using cocaine, unlike other
groups. There are control measures put in place to protect the

subjects from harm that might occurs as a result of the
experiments. Despite the fact that the research is being carried
out by the University students, the process is guided by
professionals and therefore expert advice as well as careful
analysis is used.
In an event that the subjects get stressed out during the process,
psychological experts are available for professional advice and
motivation. Sensitive information will be required regarding
social problems and this will be kept confidential without
existence of documents showing the content of the interaction
between the researcher and the subject.
6. Subject Recruitment and Selection: Briefly explain and
address the following:
a) Which of the following will be used to find and recruit
subjects? (check all that apply and include copies with
this application)
(|_|) Flyers (|_|)
Email Announcement
(|_|) Events, Meetings, Conferences (|_|) Area
Canvassing
(|_|) Phone Solicitation (|_|)
Registry
(|X|) Newspaper/Radio/Television (|_|)
Referrals from Others
(|_|) Institutional “gatekeepers” (|_|)
Direct Mail

(|_|) Face to Face Interaction (|_|)
Internet/Websites
(|_|) Bulletin Board Post (|_|)
Social Media (e.g. LinkedIn, Facebook, etc.) (please specify
Comment by owner: I don’t completely understand the
newspaper/radio/television method if we’re going to broadcast
it to the prisons over the USA. Everyone won’t have a fair
chance. What do y’all think about direct mail? Phone
Solicitation?
(|_|) Poster
below; documented use permission is required)
(|_|)
PhoenixConnect (please note if this is used,
separate prior approval through the UOPX
Committee on Research must be documented)
(|_|) Other (please
specify)____________________________________________
EXPLAIN AND DESCRIBE HERE IF SOCIAL MEDIA
WILL BE USED ____________________________________
b) What is the anticipated sample size?
(|_|) 10 or less (|X|) 11-20 (|_|) 21-50 (|_|) 51-99
(|_|) 100-199 (|_|) 200 or more
c) Will any external parties (such as editors, translators,
interpreters, statisticians, etc.) provide assistance for
recruitment purposes? (This does not pertain to persons
who assist recruitment by “snowball sampling”.)
(|_|) No (|_|) Yes (please identify and explain
how they will assist) _____________________________

d) Are any of the research subjects’ students, employees, or
patients of the researcher?
(|_|) Yes (|X|) No
e) If any potential subjects under the age of 18 years are not
selected to participate in this study, what activities
will they be doing during the time the subjects are
participating in the study so that they do not feel excluded
or left out? If this scenario does not pertain to the study,
please indicate “Not applicable” here.
f) Please briefly describe the criteria that will be used to
determine the inclusion or exclusion of subjects for
this study.
g) Will any compensation or remuneration be given to
subjects for their participation in this study?
(|_|) No (|X|) Yes (please identify amount and
type, and the plan for dissemination.
$80 per session for commitment
PLEASE PROVIDE HERE (OR AS AN ADDENDUM TO
THIS APPLICATION) ANY ADDITIONAL INFORMATION
OR EXPLANATION CONCERNING THE ABOVE
QUESTIONS THAT YOU THINK MAY BE HELPFUL TO THE
IRB REGARDING THE RECRUITMENT OF SUBJECTS FOR
YOUR RESEARCH STUDY.
7. Informed Consent: Briefly explain and address the

following questions.
a) How will subjects be informed of the study’s purpose,
procedures, intent, duration of the study and any
potential risks or discomforts to them? Check all that
apply:
(|_|) Informed Consent form (|_|) Email (|X|) Letter
(|_|) Meeting (|_|) Phone Call (|_|) Other _______
b) How will subjects be informed of withdrawal
procedures? Check all that apply:
c) How will the researcher contact information be provided
to the subjects? Check all that apply:
d) How will subjects withdraw from the study as
participants after data collection is completed?
(|_|) Email the researcher (|_|) Phone call to researcher
(|X|) Submit withdrawal form
(|_|) Other (please specify)
_____________________________________________________
______
e) Please explain what subjects must do to withdraw from
the study after data is collected and how subject data
will be retrieved and handled to ensure security and
confidentiality.
The subjects must submit the withdrawal form and sign for
withdrawal. The subject data will be stored as softcopy and
encrypted for security reasons. There will be a backup

mechanism in case of data loss.
f) If any subjects are under the age of 18 years, parental
consent is required. What provision is made to
answer any questions the parents have about this study or
to address any individual concerns? (For example,
will there be an informational meeting with the parents,
etc.?) If this scenario does not apply to this study,
please indicate “Not applicable” here.
Not applicable
OR EXPLANATION THAT YOU THINK MAY BE
HELPFUL TO THE IRB REGARDING ANY OF THE ABOVE
QUESTIONS OR ABOUT THE INFORMED CONSENT
FOR YOUR RESEARCH STUDY.
PLEASE READ AND CONFIRM THROUGH CHECK
MARKING THE BOXES BELOW:
|X| I attest that no primary data collection from human
subjects will occur without a prior signed Informed
Consent form completed for each subject and that
Informed Consent documentation will be retained
separately from study data.
|X| I attest that a process for subject withdrawal will be
implemented whereby subjects may withdraw without
penalty before, during and after data collection has

been completed and submitted and that the
information they provided will be identified, secured,
withdrawn and kept confidential.
8. Confidentiality and Privacy: Briefly explain and address
how the identity and privacy of the individual subjects will be
protected. Check any of the following that apply:
a) How will subject identity and data be protected?
(|_|) Subject names will not be used or identified
(|_|) Pseudonyms or numbers will be used instead of
subject names
(|X|) Data will be coded alphanumerically
________________________________________________
b) Will any audio and/or video tape or other recording of
data be done in this study?
(|_|) Yes (|X|) No
c) How long will the study data be kept after study
completion?
(|_|) Three years (please note this is the minimum
required retention time)
(|X|) More than three years
d) Where will the data be stored:
(|_|) In an office or other location at the researcher’s
residence
(|X|) At an office at the researcher’s place of
employment
(|_|) At a third party facility (please specify)
________________________________
______________________________________________

e) How will data be destroyed at the appropriate time?
(|_|) Shredding (|_|) Burning or incineration
(|_|) Smashing (|X|) File Deletion
______________________________________________
f) How will the results of this study be disseminated?
(|X|) Publication (|_|) Presentation (|_|)
Other _____________________________
OR EXPLANATION CONCERNING THE ABOVE THAT YOU
THINK MAY BE HELPFUL TO THE IRB REGARDING
CONFIDENTIALITY AND PRIVACY CONCERNS
ASSOCIATED WITH YOUR RESEARCH STUDY.
PLEASE READ AND CONFIRM THROUGH CHECK
MARKING THE BOX BELOW:
|X| I attest that the data from this research will be kept in
a secured location for at least three years following
study completion, and then will be permanently
destroyed.
Current version 032012
2

Best Approach to Treating Cocaine Addiction
Psychology 335
February 16, 2015
Professor
Running head: BEST APPROACH TO TREATING COCAINE
ADDICTION
1
BEST APPROACH TO TREATING COCAINE ADDICTION
2
Best Approach to Treating Cocaine Addiction
The current research that Rawson et al. (2002) notes that
methadone treatment is deemed the best treatment for cocaine
addiction Methadone is a synthetic agent that occupies the
receptors in the brain that have previously been occupied by
cocaine in order to relieve euphoria, intoxication and
withdrawal symptoms. The real issues arise from the length of
methadone treatment. Even though, research shows that, no ill
effects occur from continual use. However, the Center for
Disease Control (2002) shows that most patients under
methadone abandon the treatment before a year is complete; the
clinic sometimes encourages the patients to leave or the patients
fail to comply with the program. A more apparent reason is that
taking methadone becomes difficult and unpleasant for most
patients. In effect, most methadone patients relapse and start
using cocaine again. In this light, the question of which
treatment approach is best for treating cocaine addicts still
remain. Other drug addiction treatments, such as CBT

(Cognitive-Behavioral Therapy) and CM (Contingency
Management) show promise in helping dissuade patients from
using, even after the initial drug treatment is stopped. In this
light, there is legitimacy in the potential to create an effective
cocaine treatment by drawing from the use of CBT and CM after
the initial treatment of methadone maintenance.
Research Question
What is the best approach to treating cocaine addiction?
Hypothesis
People taken off methadone maintenance treatment who
continue their other treatments (CBT and CM) will have greater
success at beating their addiction than people who continue with
methadone maintenance treatment.
.
Sampling Method
According to the American Gastroenterological Association
(2015), during patient sampling, the sample surveyed must
represent the patient population under study. In this case, the
first approach to sampling patients is identifying the patient
characteristics. In this research, the patients under the study
will be separated into two groups. One group of patients will
have continued their initial methadone treatment (1 year) and
been placed under CBT and CM. The other group will be
comprised of patients who are continuing with methadone as a
standalone treatment after one year. Information regarding such
patients will be collected from three major hospitals dealing
with cocaine addicts. Once a list of patients from the two
groups is formed and their consent to participate in the research
obtained, random sampling of each group of patients will take
place. Random sampling is ideal because it ensures that
variations between the selected sample and actual population
are by chance, not selection bias. Stratified random sampling
will be specifically used where potential patients are divided
into the two groups and then select patients randomly from each
sample.

Using the Survey Systems, an online calculator that determines
the sample size, this research will recruit 384 participants. This
is based on a confidence level of 95%, confidence interval of +
or -5%, the national population of cocaine addicts (not users),
which is roughly 1,000,000. Hence, more potential participants
from both groups should be obtained to allow random selection
of 192 participants per group (American Gastroenterological
Association, 2015).
Statistics Employed
The research study will employ both inferential and descriptive
statistics. According to Banyard, and Grayson (2007),
descriptive statistics tend to quantitatively describe significant
features of information or data obtained in the research. This
simply means that descriptive statistics summarizes the data
collected in a research into more understandable language. In
this case, using descriptive statistics in the form of tables or
graphs would be of benefit in quantifying the data collected in a
manner that researchers or those reading the research can
understand. Inferential statistics will be critical because this
study because with only a small portion of the population being
under study, it would be difficult to derive any parameters that
provide the characteristics of the entire population of cocaine
addicts. In this light, inferential statistics will be critical in
generalization or drawing conclusions that will be able to tell
whether CBT and CM is likely to benefit cocaine addicts after
their initial methadone treatment when compared to cocaine
addicts who continue using methadone. The T-Test will be
particularly helpful when it comes to examining the differences
between patients using methadone and those using CBT and CM
to draw the conclusions.
Definition of variables
As Hayes (2002) notes, the independent variable is the
condition that a researcher systematically manipulates. In this
case, the independent variable is the drug treatment. This means

that CBT and CM, as well as, methadone are independent
variables. The dependent variable refers to outcomes measured
in the research, and which change when the dependent variables
undergo experimental manipulation. In this case, each person’s
response from the drug treatment offered is the dependent
variable. The control variable in this case is ensuring that each
patient had undergone the initial methadone treatment (1 year
and not more or less) to avoid biasing the application of the two
treatments (continuation of methadone, and CBT and CM).
Getting the initial treatment will ensure that each cocaine addict
has received the same level of treatment prior to introducing the
other two treatments. This will ensure that the two treatments
introduced (continuation of methadone, and CBT and CM) give
results that can be distinguished from the results of the initial
methadone treatment, thus able to examine the efficacy of each
treatment.
Operationalizing the Variables
Operationalizing variable implies finding quantifiable, valid
index and measurable index for the variables. The methadone
treatment will be measured in terms of mg/day where the
standard dose of 60-120 mg/day required by most patients will
be administered to patients. CBT and CM will be measured in
the context of sessions. Typically, considering that the group
has undergone the first-line of treatment with methadone, 3-5
sessions per week will be sufficient to yield the therapeutic
effect needed to dissuade patients from relapsing. Considerably,
for the control variable to work, urinalysis has to be conducted
to determine the cocaine content in each of the patients. This
will reveal whether the patient has relapsed and used cocaine
within the treatment period; those who have relapsed will not
qualify for the research study. In the case of effect of both
methadone treatment, as well as, the combination of CBT and
CM, in the 60-day period of conducting the research, different
measures will be applied to detect which is the most effective.
The below scale will be issued to cocaine users, and they will
be directed on how to use it (Markel, 2012).

Symptom check
On Methadone
(Tick if on methadone)
On CBT and CM
(Tick if on CBT-CM)
Extend of symptom (rate from (1-5)
1-not available
2- slight
3-serious
4- severe-but containable
5-severe -uncontainable
1
Thoughts of going back to using cocaine
2
Irritability
3
Paranoia

4.
Anxiety
5.
Restlessness
This scale will measure whether the treatments have been
effective in controlling cocaine addiction to the extent of
reducing relapses. The T-test will further be used to compare
the effectiveness of the two modes of treatment.
References
American Gastroenterological Association. (2015). A guide to
patient sampling. Retrieved from
https://www.gastro.org/practice/quality-initiatives/performance-
measures/Instructions_for_Valid_Sample.pdf
Banyard, P., & Grayson, A. (2007). Introducing psychological
research: Third edition. London. Palgrave Macmillan.
Center for Disease Control. (2002). Methadone maintenance
treatment. Retrieved from
http://www.cdc.gov/idu/facts/MethadoneFin.pdf
Hayes, N. (2002). Doing psychological research: Gathering and

analyzing data. New York, NY: Open University Press.
Markel, H. (2012). An Anatomy of Addiction: Sigmund Freud,
William Halsted, and the Miracle Drug Cocaine. London:
Vintage.
Rawson, R. A., Huber, A., McCann, M., Shoptaw, S., Farabee,
D., Reiber, C., & Ling, W. (2002). A comparison of contingency
management and cognitive-behavioral approaches during
methadone maintenance treatment for cocaine dependence. Arch
Gen Psychiatry, 59(9), 817-824
Title
ABC/123 Version X
1
Proposal Worksheet
PSY/335 Version 1
1
University of Phoenix MaterialProposal Worksheet
Each team member will pick an article for this worksheet.
Replicate these set of questions for each team member for this
worksheet.
Team member name:
Citation of article: Rawson, R. A., Huber, A., McCann, M.,
Shoptaw, S., Farabee, D., Reiber, C., & Ling, W. (2002). A
comparison of contingency management and cognitive-
behavioral approaches during methadone maintenance treatment
for cocaine dependence. Arch Gen Psychiatry,59(9), 817-824
1. What is the author’s goal? Cocaine addiction is very complex
to treat. The first line of treatment is normally methadone
maintenance, which is not fully effective, as patients remain
severely affected by cocaine use. For patients under methadone
management, CBT and CM show promising results in reducing

the use of cocaine and sustaining positive effects when patients
are discharged. In this light, the goal of the authors is
comparing the efficacy of CBT- cognitive-behavioral therapy
and CM –contingency management when combined and when
each is used independently in treating the dependence of
cocaine in patients already under methadone maintenance. This
also goes for examining if reductions achieved in using cocaine
are sustained during follow-ups conducted after treatment is
issued.
2. What questions remain unanswered? The study results show
that in the first 16 weeks, patients under CM had significant
improvement while those in CBT group showed no significant
improvement compared to those placed under methadone
maintenance only. However, after 26 weeks and during 52nd
week follow-up, patient under CBT showed equivalent
performance, as those under CM.
The unanswered question is what makes CBT group catch up
with CM group response at 52 weeks while the group had
already showed delay in achieving the response?
3. If I had to design an experiment to test this hypothesis, what
would I do? In designing an experiment to test the two
questions, I would present the hypotheses and make predictions
on the expected outcome. It could be that CBT effectiveness
starts taking place after 26 weeks or CM effectiveness slows
down after 26 weeks to allow CBT catch up with it. I would
then conduct an experimental procedure entailing a systematic
way of experimenting science. This would entail selecting
cocaine patients, as subjects randomly, dividing them into two
and assigning each half to CBT and CM group. Observing
patients in CBT and CM groups after 26 weeks keenly to see the
changes that account for the increased CBT response. I would
create schedules of observation, put controls and use a sample
that yields statistical significance.
4. What are the independent, dependent, and control variables?
In Rawson, Huber, McCann, Shoptaw, Farabee, Reiber and

Ling (2002) the dependent variable include the metabolites of
cocaine found in patients urine used to determine efficacy of
CBT, CM and sustained cocaine reductions. The independent
variables include CBT and CM, which the researchers introduce
to patients under methadone management to see how they would
response. The control variable is continuing methadone
maintenance treatment in all patients.
After reviewing each team member’s submission, answer the
following questions as a team:
1. What is your research question? What is the best approach to
treating cocaine addiction?
2. What is your hypothesis? People taken off methadone
treatment who continue their other treatments will have greater
success at beating their addiction than people who continue with
methadone.
Copyright © XXXX by University of Phoenix. All rights
reserved.
Copyright © 2014 by University of Phoenix. All rights reserved.

Institutional Review.docx

Recommended

Recommended

More Related Content

Similar to Institutional Review.docx

Similar to Institutional Review.docx (20)

More from joyjonna282

More from joyjonna282 (20)

Recently uploaded

Recently uploaded (20)

Institutional Review.docx